Paspatis Gregorios, Fragaki Maria, Arna Despoina-Eleni, Velegraki Magdalini, Psistakis Andreas, Nicolaou Pinelopi, Psaroudakis Ioannis, Tribonias George, Voudoukis Evangelos, Karmiris Konstantinos, Theodoropoulou Angeliki, Chlouverakis Gregorios, Vardas Emmanouil
Department of Gastroenterology, Venizeleion General Hospital, Heraklion, Crete, Greece.
Department of Gastroenterology, Venizeleion General Hospital, Heraklion, Crete, Greece.
Dig Liver Dis. 2025 Jan;57(1):44-50. doi: 10.1016/j.dld.2024.06.028. Epub 2024 Jul 15.
Data of long-term follow up for large non pedunculated colorectal polyps (LNPCPs) ≥4 cm removed with piecemeal wide field endoscopic mucosal resection (PWF-EMR) are limited. We primarily evaluated the recurrence rates and secondarily the rates of post colonoscopic polypectomy colorectal cancer (PCPCRC) on a long-term basis.
We retrospectively reviewed a prospectively-stored electronic database of all patients who underwent PWF-EMR for LNPCPs at the Venizeleion General Hospital, between 2009 and 2020. Eligible patients were those with LNPCPs ≥4 cm, deemed completely removed by endoscopic means and followed-up for a minimum of 36 months with at least two surveillance colonoscopies, the first one (SC1) (4-6) months after the initial PWF-EMR procedure and the second one (SC2) after (12-18) months. In 2023, all cases were checked for PCPCRC development.
Residual/early recurrent tissue was detected in 44 (31 %) cases among the 142 (82 males, 60 females) assessed during SC1. Late recurrent tissue was detected in 9 (6.6 %) cases among the 137 surveyed during SC2. Investigation did not reveal any case of PCPCRC .
This historical cohort shows that the PWF-EMR for LNPCPs ≥4 cm is a safe and definitive removal method while it is not associated with the appearance of PCPCRC.
关于采用整块广域内镜黏膜切除术(PWF-EMR)切除直径≥4 cm的大型无蒂结直肠息肉(LNPCP)的长期随访数据有限。我们主要评估了长期复发率,其次评估了结肠镜下息肉切除术后结直肠癌(PCPCRC)的发生率。
我们回顾性分析了2009年至2020年间在维尼泽利翁综合医院接受PWF-EMR治疗LNPCP的所有患者的前瞻性存储电子数据库。符合条件的患者为LNPCP直径≥4 cm,经内镜检查认为已完全切除,并至少随访36个月,至少进行两次监测结肠镜检查,第一次(SC1)在初次PWF-EMR手术后(4-6)个月进行,第二次(SC2)在(12-18)个月后进行。2023年,对所有病例进行了PCPCRC发生情况检查。
在SC1评估的142例患者(82例男性,60例女性)中,44例(31%)检测到残留/早期复发组织。在SC2调查的137例患者中,9例(6.6%)检测到晚期复发组织。调查未发现任何PCPCRC病例。
这个历史性队列研究表明,对于直径≥4 cm的LNPCP,PWF-EMR是一种安全、确定性的切除方法,且与PCPCRC的出现无关。